Matteo Lambertini, MD PhD
@matteolambe
Followers
14,557
Following
453
Media
1,320
Statuses
10,336
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge . Chair of @myESMO YOC. #BreastCancer #Fertility . Big fan of @sampdoria & @giroditalia .
Genoa, Liguria
Joined December 2012
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Merchan
• 165042 Tweets
Cauca
• 130468 Tweets
Costello
• 98222 Tweets
$ETH
• 67238 Tweets
Espinoza
• 46472 Tweets
Intelectuales
• 36419 Tweets
#WWERaw
• 29723 Tweets
#ラヴィット
• 28706 Tweets
ETH ETF
• 25587 Tweets
STRAY KIDS HITS HOT100
• 24546 Tweets
Scarlett Johansson
• 19549 Tweets
定額減税
• 17328 Tweets
#LVCRUISE25
• 13272 Tweets
FELIX ENAMORA A BARCELONA
• 13271 Tweets
BLINDAJE FURIOSO
• 11834 Tweets
Pinned Tweet
Presented today at
#SABCS23
and published in
@JAMA_current
results of our study showing the feasibility and safety of
#pregnancy
after
#BreastCancer
in young
#BRCA
carriers
@OncoAlert
@SABCSSanAntonio
@AACR
@UniGenova
@SanMartino_Ge
#bcsm
Link here:
13
69
211
Finally out in
@NEJM
results from
#POSITIVE
trial showing that temporary interruption of
#EndocrineTherapy
to attempt
#pregnancy
is safe in
#BreastCancer
patients: this is wonderful news…super congrats
@AnnPartridgeMD
@etop_ibcsg
et al!
@OncoAlert
#bcsm
9
190
530
Honored and excited to share our large
#metanalysis
presented at
#SABCS20
now published in
@ASCO_pubs
#JCO
providing solid and reassuring evidence on fetal and maternal safety of
#pregnancy
after prior
#BreastCancer
history
@OncoAlert
#SurvOnc
#bcsm
Link:
21
140
425
From January 1, 2023 I have been appointed as Chair of
@myESMO
Young Oncologists Committee
#ESMOYOC
...a big THANK YOU to all the people that have helped me to achieve this position and to those that will contribute in the next 2 years to succeed in our mission!
@OncoAlert
48
25
404
This person is a young oncologist...
This person is Italian...
This person is the discussant at the
#ASCO22
plenary session...
@ChiaraCrem1
is the Queen of Italy 🇮🇹🔥❤️🔝💪🤩
#ItalianPride
@OncoAlert
@ASCO
@ASCOPost
@ConquerCancerFd
@JCO_ASCO
@AIOMtweet
14
26
347
..the second best day of my life..benvenuto Ruggero..Giulia, Agnese and I are so excited to welcome you in our family!!! 💙👨👩👧👦🎉
#RuggeroLambertini
#welcome
#FamilyIsGrowing
#FamilyFirst
#proudDaddy
#pap
àbis
#doubledad
#6thSeptember2021
#OspedaleSanMartino
#UNIGE
#UNIGEnonsiferma
39
3
316
Finally out the
#ASCO23
Educational Book with our contribution on managing menopausal symptoms,
#fertility
preservation & bone health in
#BreastCancer
patients receiving
#EndocrineTherapy
Link for free download:
@ASCO
@kristinrojasmd
@Lucarecco
@OncoAlert
10
76
277
Finally the controversy on
#carboplatin
use as part of neoadjuvant
#chemotherapy
in triple-negative
#BreastCancer
patients is over: super congrats to our Indian colleagues for running such an important academic trial!
@OncoAlert
@SABCSSanAntonio
@Poggio_Fra
#bcsm
#SABCS22
6
81
268
February 1, 2022
Finally, super excited and honored to become Associate Professor in medical oncology at
@UniGenova
@SanMartino_Ge
...many many thanks to all the people that have supported me over the past years...ready for this new challenge !
@OncoAlert
#UNIGEnonsiferma
#UNIGE
33
8
266
Finally out in
@ASCO_pubs
our
#ASCO19
data: strong evidence to state that
#pregnancy
after
#BreastCancer
is safe in patients with germline
#BRCA
mutations and should not be discouraged
@ASCO
#OncoAlert
#JCO
#bcsm
#UNIGEnonsiferma
@UniGenova
@SanMartino_Ge
18
98
232
Finally it’s time for the
#DESTINYbreast04
trial at
#ASCO22
plenary session: so excited to be in the 2nd row of this big room to see such unprecedented results in the
#BreastCancer
field...this will remain one of the most important moment in the history of this disease
@OncoAlert
3
45
220
Updated results from
#MONARCH3
at
#ESMO22
: addition of
#abemaciclib
to an aromatase inhibitor improves overall survival in endocrine sensitive advanced
#bcsm
(not significant at this interim analysis but to me clinically relevant: mOS=67 months, >1y gain)
@OncoAlert
@myESMO
7
75
217
Excited to share our
@TheLancetOncol
review on how to manage side-effects of adjuvant
#EndocrineTherapy
in
#BreastCancer
patients
@AliceFranzoi
@ElisaAgostinett
@MartaPerachino
@E_de_Azambuja
@delmastro_lucia
@inesvazluis
@YoungStrongDFCI
@OncoAlert
#bcsm
10
69
214
So excited to see in person these data...no comments needed!!!!
#ESMO21
#PresidentialSession
@myESMO
@OncoAlert
@JavierCortesMD
#DESTINYbreast03
5
53
211
A few hours before
#ASCO22
plenary session, out in
@NEJM
results of
#destinyBreast04
trial showing impressive survival improvement (doubling of PFS with HR 0.51 and major OS gain) with
#TrastuzumabDeruxtecan
in
#HER2
-low advanced
#BreastCancer
@OncoAlert
2
68
208
Here the new algorithm to treat patients with advanced
#HER2
-positive
#BreastCancer
after
#ESMO21
presidential session! Will we be finally able to cure some of them??
@myESMO
@OncoAlert
#bcsm
2
69
202
Finally out in
@Annals_Oncology
updated
@ESOncology
@myESMO
International Consensus Guidelines for
#BreastCancer
in young women...looking forward to the sixth edition taking place online on October 8 !
#BCY5
@OncoAlert
#bcsm
@YSCBuzz
@AnnPartridgeMD
3
89
203
Finally out
@myESMO
guidelines on
#fertility
preservation and post-treatment
#pregnancies
in post-pubertal
#cancer
patients: extraordinary
#oncofertility
team effort !
@Annals_Oncology
#OncoAlert
#SurvOnc
#UNIGE
#UNIGEnonsiferma
@UniGenova
@SanMartino_Ge
13
73
184
July 16, 2019
The best day of my life!!! Finally Agnese has joined our family!!!
A special acknowledgment to Dr. Anserini and Dr.
@maclaudiaa
for their work today at
@SanMartino_Ge
and for giving us the opportunity to live such emotions!!!
#TheBestDayEver
#Daddy
#Agnese
40
2
185
Looking forward to be on site in
#Paris
at
#ESMO21
to finally "hug" again many friends after so long and to hear all the exciting news in the
#BreastCancer
field with several important practice changing data: I am sure it will be an unforgettable
@myESMO
event!
#Top10
@OncoAlert
8
61
174
More biomarkers are now needed to define the optimal
#treatment
algorithm for patients with advanced
#HormoneReceptor
-positive
#BreastCancer
#SABCS20
#OncoAlert
@OncoAlert
#bcsm
#BRCA
#PIK3CA
#ESR1
0
52
168
Presented at
#SABCS22
results from
#RIGHT
trial on
#ribociclib
+ endocrine therapy vs. chemotherapy as first-line therapy in metastatic aggressive HR+/HER2-
#BreastCancer
: very very important data to STOP using
#chemotherapy
in this setting !
@OncoAlert
#bcsm
@SABCSSanAntonio
7
49
166
Finally out in
@NEJM
updated results of
#KEYNOTE522
showing improved event-free survival (& pCR) with
#pembrolizumab
added to standard
#chemotherapy
(including
#carboplatin
) in early TripleNegative
#BreastCancer
: historical moment!
@OncoAlert
#bcsm
#TNBC
2
62
159
Two
@NEJM
articles this week showing worse survival outcomes with minimally invasive radical
#hysterectomy
as compared to
#OpenSurgery
among women with
#CervicalCarcinoma
: newer does not always mean better !
7
98
155
Honoured to have our IPD
#metanalysis
on the role of
#GnRHa
during
#chemotherapy
published in
@JCO_ASCO
; our
#young
#BreastCancer
patients have now an available option to reduce the risk of developing chemotherapy-induced early
#menopause
and
#infertility
5
57
149
Here my selection of the top 10
#BreastCancer
#abstracts
to presented at the upcoming 2019
#ASCO
Annual Meeting in
#Chicago
from May 31 to June 4: "Caring for Every
#Patient
, Learning from Every Patient"
#ResearchSavesLives
#OncoAlert
#bcsm
@ASCO
@OncoAlert
@ASCOPost
7
56
153
Out in
@NEJM
overall survival data from
#KEYNOTE355
trial showing benefit of adding
#pembrolizumab
to chemotherapy as 1st-line treatment in advanced
#PDL1
+ triple-negative
#BreastCancer
: congrats super
@JavierCortesMD
@hoperugo
et al!
@OncoAlert
#bcsm
5
58
152
Out in
@Annals_Oncology
updated EFS results of our metanalysis on neoadjuvant
#platinum
-based
#chemotherapy
for triple-negative
#BreastCancer
(6 RCTs, n=1,681): highly positive effect for addition of
#carboplatin
--> SoC in fit patients
@OncoAlert
#bcsm
3
66
151
So excited to share our results on
#contraceptive
use in
#BreastCancer
patients, a very important but neglected issue..super grateful to
@dimeglio_anto
@ines_vazluis
@FAndreMD
and all
#CANTO
investigators
@JAMANetworkOpen
@JAMANetwork
@OncoAlert
Link:
4
43
152
Getting ready for an exciting
@SABCSSanAntonio
: here my
#Top10
selection among the many expected important studies and my
#Top5
abstracts on
#BreastCancer
in young women with an important contribution by our
@UniGenova
@SanMartino_Ge
group!
@OncoAlert
#UNIGEnonsiferma
#bcsm
#BCY
6
38
149
After a long night shift, energy already fully recovered after finding in my mail box the
@ConquerCancerFd
Merit Award certificate: grateful to
@ASCO
for the chance to present our study on safety of
#pregnancy
in
#BRCA
-mut
#BreastCancer
patients
#ASCO19
@SanMartino_Ge
@UniGenova
21
8
148
Wow...what a masterpiece by
@CristinaSaura3
and our
@VHIO
colleagues published in
@AACR
journal
@CD_AACR
showing that
#ctDNA
can be detected in breast milk...this has potential implications for
#BreastCancer
screening in young women
@OncoAlert
#bcsm
3
52
147
Looking forward to being finally in person again at
#ASCO22
: while preparing for the conference, I have selected my favorite
#Top10
abstracts in
#BreastCancer
and
#Top5
focused on young patients
#BCY
...major advances awaited!
@OncoAlert
@ASCO
@UniGenova
@SanMartino_Ge
@ASCOPost
0
47
147
Someone is getting excited with the
#ASCO21
plenary session (or is actually asking his dad to give her attention!)🙈🥰
7
3
140
Finally the
#ASCO21
abstracts are now available: here my selection of the
#Top10
#BreastCancer
abstracts &
#Top5
specifically focused on young women
#BCY
Link to the abstracts:
@ASCO
@OncoAlert
@UniGenova
@SanMartino_Ge
#bcsm
#UNIGEnonsiferma
#OncoAlert
3
47
144
Hope that our Italian
#YoungOncologists
perspective published in
@myESMO
journal
@ESMO_Open
can be helpful to
#oncologists
facing the challenges associated with
#cancer
care during
#COVID19
outbreak
#OncoAlert
@SanMartino_Ge
@UniGenova
@AIOMtweet
Link:
7
72
141
Very important week for endocrine sensitive HR+/
#HER2
- metastatic
#BreastCancer
: updated data from
#MONALEESA2
(out in
@NEJM
) and
#MONARCH3
showing consistent median overall survival exceeding 5 years with
#ribociclib
or
#abemaciclib
+ ET
@OncoAlert
#bcsm
2
43
135
...finally at
#ESMO21
median overall survival of patients with metastatic
#HormoneReceptor
-positive/
#HER2
-negative
#BreastCancer
is reported to exceed 5 years in a
#RCT
...still a lot of work to do for curing these patients but this is a very important result!
@OncoAlert
@myESMO
2
39
136
Excited to see in
@Nature_NPJ
our
#SABCS20
data on clinical behavior & outcomes of
#BreastCancer
in
#young
women with germline
#BRCA
mutations: huge academic effort & important step to improve the care of these patients
@OncoAlert
#bcsm
@SABCSSanAntonio
3
36
132
Updated data from
#monarchE
trial just presented at
#ESMOVirtualPlenary
showing increased magnitude of benefit for the addition of
#abemaciclib
to adjuvant
#EndocrineTherapy
in high-risk HR+/HER2-
#BreastCancer
patients: very important data!
@myESMO
@OncoAlert
@Annals_Oncology
3
58
130
Expected to be presented at the
#ASCO21
plenary session,
#OlympiA
trial is already published in
@NEJM
: impressive results with adjuvant
#olaparib
in
#BRCA
mutated
#BreastCancer
patients (8.8% absolute benefit in 3-y iDFS; HR 0.58)
@ASCO
@OncoAlert
#bcsm
1
40
128
Our study on pregnancy after
#BreastCancer
in young
#BRCA
carriers made it to the first
@JAMA_current
issue of 2024...what a great way to start the year!
@OncoAlert
@UniGenova
@SanMartino_Ge
@AnnPartridgeMD
@BlondeauxEva
#bcsm
Link to the full article:
8
37
125
Ok...I’m not in
#Berlin
but this is pretty cool way of working from the beautiful countryside of
#Genova
in
#Liguria
,
#Italy
!
And from where are you following
#ESMOBreast20
??
@myESMO
#OncoAlert
#congresswithmyfamily
#lovemyjob
@SanMartino_Ge
@UniGenova
#unigenonsiferma
16
7
124
After a great
#ESMObreastPreceptorship
, time to celebrate my 36th
#birthday
with my special family...feel so lucky and grateful to have
#Agnese
and
#Ruggero
with us!
Thank you very much for all the birthday wishes I’ve received today!
@myESMO
@OncoAlert
@UniGenova
@SanMartino_Ge
11
0
122
Finally online in
@NatureCancer
phase II data showing the clinical activity of single agent
#talazoparib
in patients without germline
#BRCA
PVs but with other defects in homologous recombination genes like germline
#PALB2
PVs
@OncoAlert
#PARPi
#bcsm
Link:
2
45
120
The most special day of the year has finally arrived…merry Christmas everyone!!! ❤️💝💙👨👩👧👦🎅🏻🎄
@OncoAlert
@UniGenova
@SanMartino_Ge
#UNIGEnonsiferma
#genovamorethanthis
13
3
121
Great updated review article on
#oncofertility
just out in
@CBCjournal
by
@MRazeti
&
@UniGenova
@SanMartino_Ge
team: hope it can help improving the counseling of young
#BreastCancer
patients
Free download for 50 days:
@OncoAlert
#UNIGEnonsiferma
#bcsm
5
44
118
Kindly share your opinion on our suggested algorithm (online in
@SAGEPublishers
journal
#ClinMedInsightsOncol
) for the current
#adjuvant
systemic treatment of
#premenopausal
early
#BreastCancer
patients
#OncoAlert
#bcsm
#BCY
#UNIGEnonsiferma
#UNIGE
Link:
4
72
112
General session 3 at
#SABCS21
: more data from
#DESTINYBreast03
in patients with advanced
#HER2
+
#BreastCancer
...my only comment is actually a request...from Monday morning onwards, please let me offer 2nd line
#TrastuzumabDeruxtecan
to all my patients...
@OncoAlert
#bcsm
#TDXd
2
36
116
Important study out in
@NatureComms
showing that postpartum
#BreastCancer
has a distinct molecular profile that may potentially explain the poorer outcomes of these patients: CDK4/6 inhibition and
#immunotherapy
to be implemented here
@OncoAlert
#PPBC
Link
2
46
117
Honored and excited for this
#award
...always grateful to my super mentors
@delmastro_lucia
from
@UniGenova
@SanMartino_Ge
and
@E_de_Azambuja
from
@JulesBordet
!
@OncoAlert
@MDPIOpenAccess
@CurrentOncology
#UNIGEnonsiferma
#UNIGE
#OspedaleSanMartino
#ResearchSavesLives
#Oncology
🥇Congratulations to the winner of the CO 2021 Young Investigator Award:
Dr. Matteo Lambertini
@matteolambe
👏👏
🗨️He is clearly a rising star in the field of clinical breast oncology.
👉
Thanks to all the nominators and nominees for their participation!
0
2
39
16
10
116
How to interpret the overall survival data with first-line CDK4/6 inhibitor plus endocrine therapy in HR+/HER2- advanced
#BreastCancer
? And how to choose among the 3 available options ?
#ESMO22
@OncoAlert
@myESMO
#bcsm
1
37
115
Updated data from
#MONALEESA3
trial at median follow up of 70.8 months (!!) presented at
#ESMObreast22
: exciting to see another trial showing median
#OS
beyond 5 years in patients with metastatic endocrine sensitive HR+
#HER2
-
#BreastCancer
receiving
#ET
+
#ribociclib
@OncoAlert
0
36
114
This is going to be a great and successful
@myESMO
annual conference for
#BreastCancer
(hoping to see you in person next year at
#ESMO21
): important science including results from 5 new RCTs expected to be presented at
#ESMO20
#OncoAlert
#ResearchSavesLives
#StopCOVID19
#top10
5
49
111
In exactly one week from now! A big dream finally coming true: presenting in an educational session at
@SABCSSanAntonio
#SABCS22
with my super US mentor
@AnnPartridgeMD
from
@DanaFarber
! Looking forward to December 9, 3-5 pm San Antonio time 🥰🤩💪😎✌️
@OncoAlert
#UNIGEnonsiferma
2
9
115
Excellent overview about
#BreastCancer
biology by
@PenaultLlorca
at
@myESMO
preceptorship:
#ER
#PR
and
#HER2
are not enough anymore to guide treatment choice in the advanced setting
@OncoAlert
@curijoey
@E_de_Azambuja
#esmopreceptorshipbc
#ESMO
#EducationIsKey
#StopCOVID19
#bcsm
1
45
106
Published in
@JAMAOnc
@JAMANetwork
3-year survival data from the
#ISPY
trial: further evidence to support the strong prognostic value of achieving
#pCR
after
#neoadjuvant
therapy in early
#BreastCancer
regardless of subtype
#OncoAlert
#bcsm
@OncoAlert
3
38
108
Super proud of
#ESMOYOC
team and grateful to
@DrJonLim
for leading on such an important position paper on role and future of the clinician-scientist in
#oncology
, a key topic for many YOs
@ESMO_Open
@myESMO
@OncoAlert
@AIOMtweet
@TeresaSAmaral
@UniGenova
3
42
108
Important start of 2023 with our
#NeoALTTO
gonadotoxicity analysis: weekly paclitaxel +
#trastuzumab
should not be considered completely gonadal safe...proper
#oncofertility
counseling is mandatory also in these women
@OncoAlert
#bcsm
#BreastCancer
#HER2
2
32
109
Great effort within
@BIGagainstBC
ALTTO trial led by super
@ElisaAgostinett
out in
@Nature_NPJ
showing that
#PREDICT
should not be used to give prognostic estimations to
#HER2
+ early
#BreastCancer
patients treated in the modern era
@OncoAlert
#bcsm
Link:
2
34
106
Looking forward to
#ASCO21
: important data by the Italian
#BreastCancer
group
#GIM
with the final analysis of
#PROMISE
-
#GIM6
trial on
#GnRHa
use during
#chemotherapy
for ovarian function preservation
@OncoAlert
#UNIGEnonsiferma
#bcsm
Full abstract here:
1
29
106
Finally the day has arrived...just moved to our new apartment!!! First lunch, sunset view from our terrace and dinner that we will never forget!!! Grateful to all the people that have made this possible ❤️
#newlife
#theThreeOfUs
#Genova
#Liguria
#GenovaMoreThanThis
#FamilyFirst
6
3
106
Great to be finally back to the soccer field with the
@ASCO
vs
@myESMO
game during
#ASCO22
: here the pre- and post-match pics 😝💪🔝🤩
@FAndreMD
@ggabuin
@M_Tagliamento
@FiteniFrederic
@dr_FPetracci
@jo_ciccolini
9
10
105
Very pragmatic algorithm proposed by the great
@hoperugo
to optimize the
#neoadjuvant
treatment of
#TripleNegative
#BreastCancer
patients
#ESMO19
#OncoAlert
8
40
104
Our study on the safety of
#pregnancy
after
#BreastCancer
in
#BRCA
carriers is in the September issue of
@ASCO_pubs
#JCO
Final reference is: Journal of Clinical Oncology 38, no. 26, 3012-3023
#OncoAlert
#ASCO19
#UNIGEnonsiferma
@UniGenova
@SanMartino_Ge
3
29
104
Happy 8-month anniversary to my princess Agnese...I will hug again my family after this
#COVID19
nightmare will be under control...please help us and our
#cancer
patients to succeed in this battle...
#StayAtHome
#stateacasa
#unitisivince
#PrayForItaly
#standwithitaly
#FuckCOVID19
4
3
105
Ok let's be honest...I don't like virtual conferences that much...but this is probably the only opportunity to follow
@myESMO
Presidential Session with my two ladies wearing a
@sampdoria
t-shirt !!!
Looking forward to the adjuvant
#abemaciclib
data !
#ESMO20
#FamilyFirst
#UNIGE
8
3
103
#ESMO19
Presidential Session abstract 3 - results from
#KEYNOTE522
: significant improvement in pCR and trend for event free survival with the addition of
#pembrolizumab
to neoadjuvant
#chemotherapy
in early
#TripleNegative
#BreastCancer
#bcsm
#OncoAlert
@OncoAlert
@myESMO
0
53
100
And finally I have met the great
@DrJNaidoo
!!!
So exciting to work together in helping to build a super
#ESMO24
program for next year
@myESMO
congress in
#Barcelona
…stay tuned !!!
@UniGenova
@SanMartino_Ge
#UNIGEnonsiferma
4
6
104
This is my top 1 abstract on
#BreastCancer
in young women to be presented at
#ASCO22
by my friend Dr. Kim from
@AsanMedicalCtr
: at more than 8-y median follow-up, addition of
#OFS
to
#tam
in
#chemo
pretreated patients increases DFS by absolute 5.2% (HR 0.67)..congrats!
@OncoAlert
3
23
100
General session 1 at
#SABCS21
: super discussion by the great
@hoperugo
on current knowledge and unmet needs about
#immunotherapy
for patients with
#TripleNegative
early and advanced
#BreastCancer
!
@OncoAlert
#bcsm
#IO
#ImmOncol
0
47
102
The most important trial presented at
#SABCS22
: at short-term follow-up, the
#POSITIVE
study shows that in selected young women with
#BreastCancer
a temporary interruption of
#EndocrineTherapy
for having a
#pregnancy
should be considered safe!
@OncoAlert
@SABCSSanAntonio
#bcsm
3
38
99
Updated results from the
#ShortHER
randomised trial comparing 9 weeks vs 1 year of adjuvant
#trastuzumab
in patients with
#HER2
+ early
#BreastCancer
presented at
#ESMOBreast21
@myESMO
@OncoAlert
#bcsm
0
32
100
Extensive review on the state of the art in
#BreastCancer
treatment by the group of
@DrEricWiner
from
@DanaFarber
published in
@JAMA_current
: a huge progress has been made in the last decades but still a lot of work remains to be done
#bcsm
1
54
98
Eighth oral
#BreastCancer
abstract at
#ASCO22
: very important
@NRGonc
trial unfortunately showing no additional benefit of adding local treatment (
#SBRT
and/or surgery) to systemic therapy in patients with oligometastatic disease
@OncoAlert
#bcsm
@ASCO
@Icro_Meattini
4
36
97
Finally super
#DESTINYbreast03
data presented at
#ESMO21
are out in
@NEJM
:
#TrastuzumabDeruxtecan
is the new standard 2nd line therapy in
#HER2
+ advanced
#BreastCancer
..congrats (and thanks)
@JavierCortesMD
et al for this terrific trial!
@OncoAlert
#bcsm
0
47
98
Final results from
#EMBRACA
trial online in
@Annals_Oncology
showing no overall survival benefit with
#talazoparib
versus
#chemotherapy
in patients with advanced
#HER2
-negative
#BreastCancer
and germline
#BRCA
pathogenic variants
#OncoAlert
#bcsm
@myESMO
4
37
95
First meeting of the new
#ESMOYOC
: so proud to be part of this dream team & looking forward to many important projects for our young
@myESMO
members!
@franclongo
@DrJonLim
@EMariamidze
@kfoury_maria
@rillepihlak
@pawel_sobczuk
@Rodrosb
@DrLizConnolly
@DrHongchengZhu
@kevinpunie
4
14
98
For those of you taking care of premenopausal
#BreastCancer
patients, this is our proposed algorithm for the adjuvant
#EndocrineTherapy
recently published in
@JCO_ASCO
: looking forward to knowing your opinion and practice in this setting
#OncoAlert
#bcsm
4
50
96
Proud of
@Shah_ONCO
presenting at
#ESMOAsia20
the results of an international survey investigating physicians' knowledge and attitudes on
#fertility
and
#pregnancy
issues in young
#BreastCancer
patients: thanks to
@M_Tagliamento
for the analyses!
@OncoAlert
#UNIGEnonsiferma
#bcsm
3
22
97
Completely agree with this slide: local regional therapy in
#BreastCancer
patients with de novo stage IV disease should not be routinely used but it still has some role...and what about local treatment in oligometastatic disease?
#ASCO20
#PlenarySession
#bcsm
@OncoAlert
5
24
94
Back together again!!!! Missed you so much!!!! If you apply to a
@myESMO
fellowship, it ends up that your mentor becomes one of you best friend...keep that in mind!!!!
@E_de_Azambuja
🥰
#ESMO21
#ESMOYOC
2
5
97
Really looking forward to having these data presented at
#ESMO21
and published, happy to see that my practice of adding
#carboplatin
in all
#TNBC
patients fit for this regimen is a correct choice
@myESMO
@OncoAlert
#bcsm
Link to our
@Annals_Oncology
paper:
3
30
96
Sad news for
#immunotherapy
in
#BreastCancer
just before
#ASCO19
with the phase 3
#KEYNOTE
-119 trial:
#pembrolizumab
monotherapy is not superior to
#chemotherapy
in previously-treated patients with metastatic
#TripleNegative
disease
#TNBC
#OncoAlert
#bcsm
8
70
97
..I will miss a lot to be in beautiful
#Chicago
this year and to see many friends..but it's so important that
#cancer
research is moving forward anyhow despite
#COVID19
: here my
#top10list
of
#BreastCancer
abstracts to be presented at
#ASCO20
#OncoAlert
#bcsm
@DrSGraff
@UniGenova
1
45
92
Feeling really thankful for what 2019 has brought to me: merry Christmas and happy new year to all of you and your families!
#familyreallymatters
#familyfirst
#AgneseLambertini
#myfirstChristmas
#thethreeofus
#Christmas2019
9
2
93
Extensive review on
#immunotherapy
for
#cancer
treatment during
#pregnancy
just out in
@TheLancetOncol
: crucial issue, so grateful for the chance to contribute!
Free download here:
@OncoAlert
#UNIGEnonsiferma
@UniGenova
@SanMartino_Ge
@HaanenJohn
#IO
2
38
93
In
@NEJM
a case report of severe immune-related enteritis after in utero exposure to
#pembrolizumab
: today at
@ABCGlobalAll
#ABC7
we discuss management of advanced
#BreastCancer
during
#pregnancy
reminding that
#immunotherapy
is contraindicated
@OncoAlert
0
16
92
---JOB OFFER---
I am hiring an early-stage researcher with expertise in cellular and molecular biology to join our
#oncofertility
team in
#Genova
If interested, kindly send me an email to matteo.lambertini
@unige
.it
Thanks for sharing
@OncoAlert
@UniGenova
@SanMartino_Ge
@AIRC_it
0
44
92
To all my
@Twitter
friends,
#MerryChristmas
and happy holidays to you and your families with the hope to hug again in 2021!
#Natale2020
#Christmas2020
#FamilyFirst
#FamilyTime
#TantiAuguri
#Genova
#GenovaMoreThanThis
#MyPrincessAgnese
#StopCOVID19
#MasksUp
#vaccine
#getTheShot
5
0
90
…I’m a bit confused here on prognostic & predictive value of
#BreastCancer
Index in premenopausal patients enrolled in
#SOFT
trial…need help from experts: results are the opposite than expected
@SABCSSanAntonio
#SABCS22
@OncoAlert
@prat_aleix
@c_sotiriou
@DrHBurstein
@LoiSher
7
21
91
Out in
@ESMO_Open
our review led by
@puglisi_fabio
's group on impact of
#checkpoint
inhibitors on
#fertility
#pregnancy
and
#SexualHealth
: we need to do more considering the limited evidence despite the wide
#immunotherapy
use
@OncoAlert
#UNIGEnonsiferma
1
40
92
Important RCT out in
@Annals_Oncology
showing non-inferiority of 5 vs. 7/10 days of G-CSF (
#filgrastim
) primary prophylaxis of
#chemotherapy
-induced febrile
#neutropenia
in early
#BreastCancer
: great editorial by
@NicoleKuderer
and
@gary_lyman
!
#OncoAlert
3
32
91
At the
@myESMO
presidential dinner with the best team ever ❤️
#ESMOYOC
#ESMO23
@DrJonLim
@EMariamidze
@kfoury_maria
@rillepihlak
@PabloMando
@DenizCanGuven1
@pawel_sobczuk
@DrLizConnolly
@Rodrosb
@kevinpunie
@ekocakavuk
@DrHongchengZhu
@mkmoutafi
@OncoAlert
3
15
90
Finally back to the
@ASCO
annual meeting!!! So excited to be here!!!
#ASCO22
🔥🎉🤟🔝💪
#UNIGEnonsiferma
@UniGenova
@SanMartino_Ge
@OncoAlert
0
2
90
December 25, 2021
I have to admit that this is my favorite moment of the year and with the kids is really special again!
To all my
@Twitter
friends, merry
#Christmas
and happy
#NewYear
hoping to meet in person and hug each other soon!
Best from the Lambertini’s
@OncoAlert
4
3
90
Very good reading on the way to
#ASCO22
with two updated
@ASCO
guidelines on:
1) management of metastatic
#HER2
+
#BreastCancer
and brain metastases:
2) systemic therapy for metastatic
#HER2
+ disease
@OncoAlert
@JCO_ASCO
#bcsm
2
33
88
26 Nov 2018
After 5 years of elementary school, 3 of secondary school, 5 of high school, 6 as medical student
@UniGenova
, 5 as oncology fellow
@SanMartino_Ge
, 3 as
#PhD
student
@JulesBordet
, I’m finally MD PhD!
A huge acknowledgment to all the people that have made this possible!
12
4
88
Body mass index
#BMI
may impact the response to
#taxane
-based
#chemotherapy
in early
#BreastCancer
: great analysis from the
@BIGagainstBC
#BIG
2-98 trial by
@ChristineDesme2
@E_de_Azambuja
@c_sotiriou
et al!
@ASCO_pubs
#JCO
#OncoAlert
#bcsm
@JulesBordet
1
31
89